Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05466_nanopub.RAAU4ZrxErbJkvqfXOuYGlLcAJ9JY-HHHUazmQQ5ZvVs4#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05466 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05466 label "R673 [drugbank:DB05466]" assertion.
- drugbank:DB05466 seeAlso DB05466 assertion.
- drugbank:DB05466 description "R673 is a novel NK1 antagonist that penetrates the blood-brain barrier, has excellent safety and tolerability and shows low P450-based drug interaction potential. The phase II program for treatment of depression and anxiety is ongoing in the US and EU.It is not clear how tachykinin antagonists exert their effect, but SP levels have been commonly linked to the functioning of limbic system with respect to anxiety and depression." assertion.
- drugbank:DB05466 identifier "drugbank:DB05466" assertion.
- drugbank:DB05466 title "R673" assertion.
- drugbank:DB05466 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05466 drugbank_vocabulary:drugbank-id "DB05466" assertion.
- drugbank:DB05466 bio2rdf_vocabulary:x-identifiers.org DB05466 assertion.
- drugbank:DB05466 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05466" assertion.
- drugbank:DB05466 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05466 bio2rdf_vocabulary:identifier "DB05466" assertion.